Industry & Policy News

[Xilis (Cision US, Inc.)] Xilis and The University of Texas MD Anderson Cancer Center announced a strategic collaboration to deploy Xilis's proprietary MicroOrganoSphere™ technology in support of pre-clinical research to accelerate the development of novel cancer therapies.

[Yale] The three Yale honorees — Roy Lederman, assistant professor of statistics and data science, Lidya Tarhan, assistant professor of Earth and planetary sciences, and Jing Yan, assistant professor of molecular, cellular and developmental biology — will each receive two-year, $75,000 fellowships.

[Nature News] The World Health Organization (WHO) has quietly shelved the second phase of its much-anticipated scientific investigation into the origins of the COVID-19 pandemic, citing ongoing challenges over attempts to conduct crucial studies in China.

[Babraham Institute] Drs. Della David and Peter Rugg-Gunn from the Babraham Institute were awarded Wellcome Discovery Awards in the round of awards made at the end of 2022. They will pursue bold and ambitious research projects, pushing the boundaries of our knowledge of fundamental biology.

[International Society for Stem Cell Research] The International Society for Stem Cell Research (ISSCR) has announced that it will present this year’s ISSCR Momentum Award to Cédric Blanpain, M.D., Ph.D., professor and director of the laboratory of stem cells and cancer at the Université Libre de Bruxelles, Belgium.

[ENA Respiratory] ENA Respiratory announced that INNA-051, a first-in-class, broad-spectrum, innate immunomodulator in development for the prophylaxis of respiratory viral infections, was found to significantly impact the course of viral infection in a Phase IIa flu challenge study.